Fingolimod significantly reduces MRI activity in paediatric-onset multiple sclerosis (MS)

Conclusion: Fingolimod significantly reduces MRI findings consistent with active disease and rate of relapses in paediatric MS. Commentary Paediatric MS accounts for 3%–5% of all cases and...

http://ep.bmj.com/cgi/content/short/108/1/50?rss=1

Source: Archives of Disease in Childhood - Education and Practice - January 19, 2023 Category: Pediatrics Authors: Chapman, L. Tags: Key publications in paediatrics: Picket Source Type: research